Lilly's baricitinib shows hair regrowth in adolescents with alopecia areata
Eli Lilly and Company (NYSE: LLY) reported that 54.1% of adolescents with severe alopecia areata achieved successful hair regrowth after ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
